000 | 03574nam a22003855i 4500 | ||
---|---|---|---|
001 | 286037 | ||
003 | MX-SnUAN | ||
005 | 20160429154438.0 | ||
007 | cr nn 008mamaa | ||
008 | 150903s2010 xxu| o |||| 0|eng d | ||
020 |
_a9781441963062 _99781441963062 |
||
024 | 7 |
_a10.1007/9781441963062 _2doi |
|
035 | _avtls000338625 | ||
039 | 9 |
_a201509030813 _bVLOAD _c201404300348 _dVLOAD _y201402060915 _zstaff |
|
040 |
_aMX-SnUAN _bspa _cMX-SnUAN _erda |
||
050 | 4 | _aR-RZ | |
100 | 1 |
_aRaffa, Robert B. _eeditor. _9314511 |
|
245 | 1 | 0 |
_aChemo Fog : _bCancer Chemotherapy-Related Cognitive Impairment / _cedited by Robert B. Raffa, Ronald J. Tallarida. |
264 | 1 |
_aNew York, NY : _bSpringer New York, _c2010. |
|
300 |
_axx, 212 páginas 27 ilustraciones _brecurso en línea. |
||
336 |
_atexto _btxt _2rdacontent |
||
337 |
_acomputadora _bc _2rdamedia |
||
338 |
_arecurso en línea _bcr _2rdacarrier |
||
347 |
_aarchivo de texto _bPDF _2rda |
||
490 | 0 |
_aAdvances in Experimental Medicine and Biology, _x0065-2598 ; _v678 |
|
500 | _aSpringer eBooks | ||
505 | 0 | _aShort Introduction and History -- Patient’s Perspective -- Oncology Nurse’s Perspective -- Oncology Pharmacist’s Perspective -- The Impact of Chemo Brain on the Patient with a High-Grade Glioma -- Neurocognitive Effects of Childhood Cancer Treatment -- The Economic Burden -- Designing Conceptual Model-Based Research in Chemotherapy-Related Changes in Cognitive Function -- Neuropsychologic Testing for Chemotherapy-Related Cognitive Impairment -- Imaging as a Means of Studying Chemotherapy-Related Cognitive Impairment -- Chemotherapy Associated Central Nervous System Damage -- Is Systemic Anti-Cancer Therapy Neurotoxic? Does Chemo Brain Exist? And Should We Rename It? -- Evaluation of Multiple Neurotoxic Outcomes in Cancer Chemotherapy -- Chemotherapy-Related Visual System Toxicity -- The Possible Role of Cytokines in Chemotherapy-Induced Cognitive Deficits -- Pharmacokinetics of Anti-Cancer Drugs Used in Breast Cancer Chemotherapy -- Combination Analysis -- Animal Models -- Chemo Brain (Chemo Fog) as a Potential Side Effect of Doxorubicin Administration: Role of Cytokine-Induced, Oxidative/Nitrosative Stress in Cognitive Dysfunction -- Effects of 5-FU -- Future Directions. | |
520 | _aThe editors of this book are professors who are engaged in research on areas that compromise the total healing of body and mind in this patient population. One particular component of the need for survivor care is the memory problems and cognitive deficits experienced by some. The condition has been given a name––actually many names, such as chemo fog, chemo brain, and others. These names reflect the belief that the cause of the problem is the chemotherapy that they received as part of their treatment. In some cases the chemo fog/’chemo brain’ is transient while in others it is of longer duration. Little is known about this problem and that fact peaked our interest and motivated this book. Therefore this book is devoted to one aspect of survivor care: chemo fog/’chemo brain’. | ||
590 | _aPara consulta fuera de la UANL se requiere clave de acceso remoto. | ||
700 | 1 |
_aTallarida, Ronald J. _eeditor. _9314512 |
|
710 | 2 |
_aSpringerLink (Servicio en línea) _9299170 |
|
776 | 0 | 8 |
_iEdición impresa: _z9781441963055 |
856 | 4 | 0 |
_uhttp://remoto.dgb.uanl.mx/login?url=http://dx.doi.org/10.1007/978-1-4419-6306-2 _zConectar a Springer E-Books (Para consulta externa se requiere previa autentificación en Biblioteca Digital UANL) |
942 | _c14 | ||
999 |
_c286037 _d286037 |